Skip to main content

Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats

Abstract

Berberine chloride (BBR) is a natural isoquinoline alkaloid extracted from medicinal herbs. It has been reported that the intestinal absorption of BBR is very low. In this study, the absolute bioavailability of BBR was studied, and the enhancing effects of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on intestinal absorption were investigated in rats. BBR injection was administrated via the femoral vein at a dose of 1.0 mg kg−1 in intravenous group, and BBR oral formulations were administrated by oral gavage at a dose of 100 mg kg−1 in BBR control (control) group and BBR-TPGS (test) group, respectively. The result showed that BBR had a very low absolute bioavailability of 0.68%, and TPGS could enhance intestinal absorption of BBR significantly. TPGS at a concentration of 2.5% could improve peak concentration (C max) and area under the curve (AUC0–36) of BBR by 2.9 and 1.9 times, respectively. The absorption enhancing ability of TPGS may be due to its ability to affect the biological activity of P-glycoprotein and thereby reduce the excretion of absorbed BBR into the intestinal lumen. This study indicated that absolute bioavailability of BBR was 0.68% in rats, and TPGS was a good absorption enhancer capable of enhancing intestinal absorption of BBR significantly.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y. Cardiovascular actions of berberine. Cardiovasc Drug Rev. 2001;19(3):234–44.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344–51. doi:10.1038/nm1135.

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin. 2004;25(4):496–502.

    PubMed  CAS  Google Scholar 

  4. 4.

    Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett. 2007;258(2):230–40. doi:10.1016/j.canlet.2007.09.007.

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Holy EW, Akhmedov A, Luscher TF, Tanner FC. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. J Mol Cell Cardiol. 2009;46(2):234–40. doi:10.1016/j.yjmcc.2008.10.011.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol. 2002;91(4):193–7.

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 1989;58:137–71. doi:10.1146/annurev.bi.58.070189.001033.

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427. doi:10.1146/annurev.bi.62.070193.002125.

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Leu BL, Huang JD. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother Pharmacol. 1995;35(5):432–6.

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Su SF, Huang JD. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab Dispos. 1996;24(2):142–7.

    PubMed  CAS  Google Scholar 

  11. 11.

    Varma MV, Sateesh K, Panchagnula R. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Mol Pharm. 2005;2(1):12–21. doi:10.1021/mp0499196.

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Wu SH, Hopkins WK. Characteristics of d-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems. Pharm Technol. 1999;23:52–68.

    CAS  Google Scholar 

  13. 13.

    Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D, Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet. 1991;338(8761):212–4.

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 1999;16(10):1550–6.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Varma MV, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci. 2005;25(4–5):445–53. doi:10.1016/j.ejps.2005.04.003.

    PubMed  Article  CAS  Google Scholar 

  16. 16.

    Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ, et al. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release. 2006;111(1–2):35–40. doi:10.1016/j.jconrel.2005.11.005.

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Misaki T, Sagara K, Ojima M, Kakizawa S, Oshima T, Yoshizawa H. Simultaneous determination of berberine, palmatine and coptisine in crude drugs and oriental pharmaceutical preparations by ion-pair high-performance liquid chromatography. Chem Pharm Bull (Tokyo). 1982;30(1):354–7.

    CAS  Google Scholar 

  18. 18.

    Gupta PK, Hubbard M, Gurley B, Hendrickson HP. Validation of a liquid chromatography-tandem mass spectrometric assay for the quantitative determination of hydrastine and berberine in human serum. J Pharm Biomed Anal. 2009;49(4):1021–6. doi:10.1016/j.jpba.2009.01.036.

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Lu T, Liang Y, Song J, Xie L, Wang GJ, Liu XD. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method. J Pharm Biomed Anal. 2006;40(5):1218–24. doi:10.1016/j.jpba.2005.09.023.

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Hua W, Ding L, Chen Y, Gong B, He J, Xu G. Determination of berberine in human plasma by liquid chromatography–electrospray ionization–mass spectrometry. J Pharm Biomed Anal. 2007;44(4):931–7. doi:10.1016/j.jpba.2007.03.022.

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S. Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech. 2010;11(3):1466–75. doi:10.1208/s12249-010-9520-y.

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Madara JL. Loosening tight junctions. Lessons from the intestine. J Clin Invest. 1989;83(4):1089–94. doi:10.1172/JCI113987.

    PubMed  Article  CAS  Google Scholar 

  23. 23.

    Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res. 1999;16(12):1812–7.

    PubMed  Article  CAS  Google Scholar 

  24. 24.

    Liu DZ, LeCluyse EL, Thakker DR. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers. J Pharm Sci. 1999;88(11):1161–8. doi:10.1021/js990094e.

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Erickson RA. Effect of 16,16-dimethyl PGE2 and indomethacin on bile acid-induced intestinal injury and restitution in rats. J Lab Clin Med. 1988;112(6):735–44.

    PubMed  CAS  Google Scholar 

  26. 26.

    Nakanishi K, Masada M, Nadai T. Effect of pharmaceutical adjuvants on the rectal permeability of drugs. III. Effect of repeated administration and recovery of the permeability. Chem Pharm Bull (Tokyo). 1983;31(11):4161–6.

    CAS  Google Scholar 

  27. 27.

    Prasad YV, Puthli SP, Eaimtrakarn S, Ishida M, Yoshikawa Y, Shibata N, et al. Enhanced intestinal absorption of vancomycin with Labrasol and d-alpha-tocopheryl PEG 1000 succinate in rats. Int J Pharm. 2003;250(1):181–90.

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgment

This work is supported by the Liaoning Provincial Science and Technology Department (2009ZX09301-012).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Xing Tang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, W., Miao, YQ., Fan, DJ. et al. Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats. AAPS PharmSciTech 12, 705–711 (2011). https://doi.org/10.1208/s12249-011-9632-z

Download citation

Key words

  • absorption enhancer
  • berberine chloride
  • bioavailability
  • P-glycoprotein
  • TPGS